Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rectal Neoplasms | 22 | 2025 | 111 | 5.840 |
Why?
|
| Colectomy | 13 | 2021 | 108 | 3.690 |
Why?
|
| Rectum | 13 | 2023 | 90 | 2.910 |
Why?
|
| Colonic Diseases | 4 | 2020 | 34 | 2.190 |
Why?
|
| Transanal Endoscopic Surgery | 8 | 2025 | 25 | 2.190 |
Why?
|
| Patient Readmission | 6 | 2020 | 429 | 2.180 |
Why?
|
| Elective Surgical Procedures | 7 | 2021 | 124 | 2.140 |
Why?
|
| Digestive System Surgical Procedures | 10 | 2021 | 90 | 2.110 |
Why?
|
| Colorectal Surgery | 6 | 2025 | 51 | 1.920 |
Why?
|
| Postoperative Complications | 17 | 2025 | 1308 | 1.920 |
Why?
|
| Colon | 6 | 2021 | 147 | 1.780 |
Why?
|
| Rectal Diseases | 3 | 2020 | 28 | 1.700 |
Why?
|
| Laparoscopy | 9 | 2023 | 492 | 1.690 |
Why?
|
| Colorectal Neoplasms | 7 | 2023 | 276 | 1.660 |
Why?
|
| Analgesics, Opioid | 3 | 2021 | 536 | 1.450 |
Why?
|
| Colonic Neoplasms | 5 | 2023 | 222 | 1.420 |
Why?
|
| Crohn Disease | 5 | 2021 | 110 | 1.270 |
Why?
|
| Diverticulitis | 3 | 2020 | 31 | 1.170 |
Why?
|
| Surgeons | 5 | 2022 | 183 | 1.060 |
Why?
|
| Length of Stay | 8 | 2021 | 812 | 0.960 |
Why?
|
| Pain, Postoperative | 3 | 2021 | 162 | 0.930 |
Why?
|
| Retrospective Studies | 22 | 2024 | 6661 | 0.930 |
Why?
|
| Fecal Incontinence | 3 | 2025 | 30 | 0.920 |
Why?
|
| Humans | 68 | 2025 | 63446 | 0.910 |
Why?
|
| Middle Aged | 31 | 2025 | 17615 | 0.910 |
Why?
|
| Risk Assessment | 4 | 2020 | 2079 | 0.900 |
Why?
|
| Constipation | 1 | 2024 | 15 | 0.890 |
Why?
|
| Diverticulitis, Colonic | 4 | 2020 | 34 | 0.860 |
Why?
|
| Patient Discharge | 4 | 2021 | 512 | 0.850 |
Why?
|
| Male | 39 | 2025 | 29889 | 0.820 |
Why?
|
| Healthcare Disparities | 3 | 2023 | 360 | 0.810 |
Why?
|
| Quality Improvement | 6 | 2019 | 443 | 0.780 |
Why?
|
| Adenocarcinoma | 5 | 2019 | 348 | 0.770 |
Why?
|
| Female | 37 | 2025 | 32878 | 0.750 |
Why?
|
| Colonic Pseudo-Obstruction | 1 | 2021 | 1 | 0.730 |
Why?
|
| Cecal Diseases | 1 | 2021 | 4 | 0.730 |
Why?
|
| Intestinal Volvulus | 1 | 2021 | 7 | 0.730 |
Why?
|
| Sarcopenia | 1 | 2022 | 24 | 0.730 |
Why?
|
| Sigmoid Diseases | 1 | 2021 | 6 | 0.730 |
Why?
|
| Surgical Wound Infection | 2 | 2014 | 115 | 0.720 |
Why?
|
| Rectal Prolapse | 2 | 2019 | 11 | 0.720 |
Why?
|
| Oxycodone | 1 | 2021 | 30 | 0.710 |
Why?
|
| Home Care Services | 2 | 2020 | 98 | 0.660 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 168 | 0.650 |
Why?
|
| Inappropriate Prescribing | 1 | 2021 | 66 | 0.650 |
Why?
|
| Aged | 21 | 2025 | 14449 | 0.650 |
Why?
|
| Colonic Pouches | 1 | 2019 | 16 | 0.640 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2019 | 19 | 0.640 |
Why?
|
| Skilled Nursing Facilities | 1 | 2020 | 83 | 0.630 |
Why?
|
| Drug Utilization | 1 | 2021 | 209 | 0.620 |
Why?
|
| Preoperative Care | 2 | 2020 | 193 | 0.620 |
Why?
|
| Anastomosis, Surgical | 5 | 2023 | 114 | 0.620 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2021 | 712 | 0.610 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2019 | 20 | 0.610 |
Why?
|
| Insurance Coverage | 2 | 2016 | 100 | 0.600 |
Why?
|
| Colitis, Ulcerative | 1 | 2019 | 74 | 0.600 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2019 | 33 | 0.600 |
Why?
|
| Treatment Outcome | 16 | 2025 | 5680 | 0.590 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2016 | 129 | 0.590 |
Why?
|
| Neoplasm Staging | 6 | 2023 | 509 | 0.560 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2015 | 34 | 0.550 |
Why?
|
| Colon, Transverse | 1 | 2017 | 4 | 0.540 |
Why?
|
| Adult | 17 | 2025 | 16823 | 0.520 |
Why?
|
| Hospital Costs | 2 | 2014 | 126 | 0.520 |
Why?
|
| Colostomy | 2 | 2023 | 24 | 0.520 |
Why?
|
| Postoperative Care | 1 | 2017 | 123 | 0.520 |
Why?
|
| United States | 14 | 2025 | 7842 | 0.510 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2020 | 102 | 0.480 |
Why?
|
| Hospitals | 1 | 2018 | 393 | 0.480 |
Why?
|
| Risk Factors | 12 | 2020 | 5353 | 0.470 |
Why?
|
| Patient Safety | 1 | 2017 | 242 | 0.460 |
Why?
|
| Intestinal Diseases | 1 | 2014 | 36 | 0.440 |
Why?
|
| Margins of Excision | 4 | 2024 | 30 | 0.440 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 161 | 0.420 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2024 | 345 | 0.400 |
Why?
|
| Anastomotic Leak | 3 | 2021 | 35 | 0.360 |
Why?
|
| Quality of Life | 6 | 2025 | 1228 | 0.350 |
Why?
|
| Cohort Studies | 5 | 2022 | 2570 | 0.330 |
Why?
|
| Health Status Disparities | 1 | 2011 | 146 | 0.330 |
Why?
|
| Intestinal Obstruction | 2 | 2023 | 53 | 0.310 |
Why?
|
| Internship and Residency | 3 | 2025 | 808 | 0.310 |
Why?
|
| Morbidity | 4 | 2021 | 113 | 0.310 |
Why?
|
| Hospital Mortality | 4 | 2017 | 877 | 0.310 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 2458 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 724 | 0.290 |
Why?
|
| Neoadjuvant Therapy | 3 | 2025 | 87 | 0.270 |
Why?
|
| Time Factors | 6 | 2019 | 3768 | 0.270 |
Why?
|
| Reoperation | 2 | 2021 | 293 | 0.260 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 5465 | 0.260 |
Why?
|
| Societies, Medical | 3 | 2024 | 379 | 0.240 |
Why?
|
| Colonoscopy | 4 | 2020 | 100 | 0.240 |
Why?
|
| Intensive Care Units | 2 | 2020 | 406 | 0.230 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 317 | 0.220 |
Why?
|
| Odds Ratio | 2 | 2020 | 768 | 0.220 |
Why?
|
| Perineum | 2 | 2021 | 19 | 0.220 |
Why?
|
| Mesocolon | 1 | 2023 | 2 | 0.210 |
Why?
|
| Surgical Stomas | 1 | 2023 | 9 | 0.210 |
Why?
|
| Anus Neoplasms | 1 | 2022 | 25 | 0.200 |
Why?
|
| Consumer Health Information | 1 | 2022 | 37 | 0.190 |
Why?
|
| Comorbidity | 2 | 2017 | 1120 | 0.190 |
Why?
|
| Critical Care | 2 | 2016 | 396 | 0.190 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2023 | 422 | 0.190 |
Why?
|
| Prospective Studies | 6 | 2025 | 3293 | 0.190 |
Why?
|
| Digestive System Fistula | 1 | 2021 | 3 | 0.180 |
Why?
|
| Neostigmine | 1 | 2021 | 3 | 0.180 |
Why?
|
| Medical Chaperones | 1 | 2021 | 3 | 0.180 |
Why?
|
| Proportional Hazards Models | 1 | 2023 | 730 | 0.180 |
Why?
|
| Organizational Policy | 1 | 2021 | 52 | 0.180 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2021 | 47 | 0.180 |
Why?
|
| Chronic Disease | 1 | 2024 | 753 | 0.180 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2021 | 74 | 0.180 |
Why?
|
| Decompression, Surgical | 1 | 2021 | 69 | 0.170 |
Why?
|
| Pelvis | 1 | 2021 | 59 | 0.170 |
Why?
|
| Ileostomy | 4 | 2023 | 27 | 0.170 |
Why?
|
| Patient Selection | 3 | 2018 | 490 | 0.170 |
Why?
|
| Clinical Competence | 1 | 2025 | 727 | 0.160 |
Why?
|
| Constriction, Pathologic | 2 | 2021 | 129 | 0.160 |
Why?
|
| Online Systems | 1 | 2020 | 20 | 0.160 |
Why?
|
| Appendiceal Neoplasms | 1 | 2019 | 8 | 0.160 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1553 | 0.160 |
Why?
|
| Multivariate Analysis | 2 | 2021 | 937 | 0.160 |
Why?
|
| Acute Disease | 1 | 2021 | 671 | 0.160 |
Why?
|
| Ischemia | 1 | 2021 | 205 | 0.160 |
Why?
|
| Long-Term Care | 1 | 2020 | 177 | 0.150 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 141 | 0.150 |
Why?
|
| Delphi Technique | 1 | 2019 | 101 | 0.150 |
Why?
|
| Lymph Nodes | 1 | 2019 | 226 | 0.150 |
Why?
|
| Universities | 1 | 2019 | 158 | 0.150 |
Why?
|
| Adolescent | 3 | 2022 | 6245 | 0.150 |
Why?
|
| Disease Management | 1 | 2020 | 232 | 0.150 |
Why?
|
| Prognosis | 2 | 2014 | 1748 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 165 | 0.140 |
Why?
|
| Frailty | 1 | 2020 | 130 | 0.140 |
Why?
|
| Education, Medical, Graduate | 2 | 2020 | 352 | 0.140 |
Why?
|
| Inpatients | 1 | 2021 | 305 | 0.140 |
Why?
|
| Self Report | 1 | 2021 | 375 | 0.140 |
Why?
|
| Social Media | 1 | 2020 | 128 | 0.140 |
Why?
|
| General Surgery | 1 | 2020 | 211 | 0.140 |
Why?
|
| Telemedicine | 1 | 2022 | 326 | 0.130 |
Why?
|
| Survival Rate | 3 | 2018 | 851 | 0.130 |
Why?
|
| Diffusion of Innovation | 1 | 2017 | 58 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 772 | 0.130 |
Why?
|
| Intestine, Small | 1 | 2016 | 79 | 0.120 |
Why?
|
| Checklist | 1 | 2016 | 73 | 0.120 |
Why?
|
| Hospitals, High-Volume | 1 | 2016 | 35 | 0.120 |
Why?
|
| Total Quality Management | 1 | 2015 | 56 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2019 | 519 | 0.120 |
Why?
|
| Dextrans | 1 | 2015 | 46 | 0.120 |
Why?
|
| Electric Stimulation Therapy | 1 | 2015 | 27 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2016 | 873 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 71 | 0.110 |
Why?
|
| Physical Examination | 1 | 2015 | 111 | 0.110 |
Why?
|
| Surveys and Questionnaires | 4 | 2025 | 2680 | 0.110 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2025 | 27 | 0.110 |
Why?
|
| Efficiency, Organizational | 1 | 2015 | 96 | 0.110 |
Why?
|
| Intestines | 1 | 2016 | 165 | 0.110 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2014 | 10 | 0.110 |
Why?
|
| Hyaluronic Acid | 1 | 2015 | 67 | 0.110 |
Why?
|
| Colonoscopes | 1 | 2014 | 3 | 0.110 |
Why?
|
| Lenses | 1 | 2014 | 9 | 0.110 |
Why?
|
| Terahertz Imaging | 1 | 2014 | 11 | 0.110 |
Why?
|
| Surface Plasmon Resonance | 1 | 2014 | 34 | 0.110 |
Why?
|
| Lasers | 1 | 2014 | 35 | 0.110 |
Why?
|
| Medical Errors | 1 | 2016 | 196 | 0.110 |
Why?
|
| Anal Canal | 1 | 2014 | 36 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 1644 | 0.100 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 102 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2014 | 162 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1094 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 311 | 0.100 |
Why?
|
| Image Enhancement | 1 | 2014 | 192 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 527 | 0.090 |
Why?
|
| Defecation | 2 | 2025 | 17 | 0.090 |
Why?
|
| Evidence-Based Medicine | 3 | 2019 | 462 | 0.090 |
Why?
|
| Age Factors | 2 | 2020 | 1558 | 0.090 |
Why?
|
| Colitis | 2 | 2015 | 77 | 0.090 |
Why?
|
| Massachusetts | 1 | 2016 | 2075 | 0.080 |
Why?
|
| Prevalence | 1 | 2014 | 1383 | 0.080 |
Why?
|
| Emergencies | 1 | 2010 | 121 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 418 | 0.080 |
Why?
|
| Logistic Models | 2 | 2010 | 1276 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 255 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 790 | 0.080 |
Why?
|
| Metabolomics | 1 | 2009 | 52 | 0.070 |
Why?
|
| Hospitalization | 1 | 2016 | 1364 | 0.070 |
Why?
|
| Operative Time | 2 | 2021 | 92 | 0.070 |
Why?
|
| Weight Loss | 1 | 2010 | 273 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 294 | 0.070 |
Why?
|
| Rectal Fistula | 1 | 2008 | 21 | 0.070 |
Why?
|
| Internet | 2 | 2022 | 469 | 0.070 |
Why?
|
| Young Adult | 2 | 2014 | 4694 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2021 | 568 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 433 | 0.060 |
Why?
|
| Smoking | 1 | 2010 | 866 | 0.060 |
Why?
|
| Early Detection of Cancer | 1 | 2009 | 322 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 1654 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 2575 | 0.050 |
Why?
|
| Search Engine | 1 | 2022 | 9 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 122 | 0.050 |
Why?
|
| Syndrome | 1 | 2022 | 180 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 82 | 0.050 |
Why?
|
| Comprehension | 1 | 2022 | 138 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 76 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2021 | 21 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 71 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2021 | 201 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2025 | 597 | 0.040 |
Why?
|
| Safety | 1 | 2021 | 145 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 142 | 0.040 |
Why?
|
| Specialty Boards | 1 | 2020 | 15 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 78 | 0.040 |
Why?
|
| Data Accuracy | 1 | 2020 | 32 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2021 | 141 | 0.040 |
Why?
|
| Stents | 1 | 2023 | 502 | 0.040 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 60 | 0.040 |
Why?
|
| Walking | 1 | 2020 | 238 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2014 | 1008 | 0.040 |
Why?
|
| Abdomen | 1 | 2018 | 91 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2019 | 199 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 264 | 0.030 |
Why?
|
| Biopsy | 2 | 2009 | 443 | 0.030 |
Why?
|
| Decision Making | 1 | 2019 | 407 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2020 | 1358 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 1645 | 0.030 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2015 | 20 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2015 | 34 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 1990 | 0.030 |
Why?
|
| Bacterial Vaccines | 1 | 2015 | 78 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 207 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2014 | 75 | 0.030 |
Why?
|
| Organ Sparing Treatments | 1 | 2014 | 16 | 0.030 |
Why?
|
| Infection Control | 1 | 2015 | 106 | 0.030 |
Why?
|
| Pelvic Floor | 1 | 2013 | 10 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 242 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 278 | 0.030 |
Why?
|
| Equipment Design | 1 | 2014 | 352 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2014 | 288 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 242 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1147 | 0.020 |
Why?
|
| Emergency Treatment | 1 | 2011 | 57 | 0.020 |
Why?
|
| Child | 1 | 2020 | 4526 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1003 | 0.020 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2008 | 5 | 0.020 |
Why?
|
| Drainage | 1 | 2008 | 154 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 2006 | 70 | 0.020 |
Why?
|
| Incidence | 1 | 2006 | 1377 | 0.010 |
Why?
|